{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:42:18Z","timestamp":1790739738997,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.humpath.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T03:12:54Z","timestamp":1515640374000},"page":"5-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors"],"prefix":"10.1016","volume":"74","author":[{"given":"Mariko","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.01.005_bb0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJM198103123041106","article-title":"Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis","volume":"304","author":"Kadin","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2018.01.005_bb0010","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0015","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"381","article-title":"Hepatosplenic T-cell lymphoma","author":"Gaulard","year":"2017"},{"key":"10.1016\/j.humpath.2018.01.005_bb0020","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0025","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma (HSTCL): A clinicopathologic, immunophenotypic, and cytogenetic analysis of 28 patients","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0030","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0035","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: A study of 7 patients who did not receive TNF-\u03b1 inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.crohns.2010.05.006","article-title":"Hepatosplenic T-cell lymphoma and inflammatory bowel disease","volume":"4","author":"Thai","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.humpath.2018.01.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-2712(18)30694-2","article-title":"Differentiation of human T cells","volume":"8","author":"Denning","year":"1988","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.humpath.2018.01.005_bb0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0952-7915(94)90125-2","article-title":"Activation and function of gamma delta T cells","volume":"6","author":"Havran","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0065","first-page":"357","article-title":"Flow cytometric and immunohistochemical characterization of the gamma\/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood","volume":"136","author":"Inghirami","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0070","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.4049\/jimmunol.143.8.2480","article-title":"Distribution of T cells bearing different forms of the T cell receptor gamma\/delta in normal and pathological human tissues","volume":"143","author":"Falini","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.2006.00472.x","article-title":"gammadelta T cells: novel initiators of adaptive immunity","volume":"215","author":"Moser","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humpath.2018.01.005_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0092-8674(94)90170-8","article-title":"The nature of major histocompatibility complex recognition by gamma delta T cells","volume":"76","author":"Schild","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2018.01.005_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-065X.2006.00470.x","article-title":"Antigen recognition by gammadelta T cells","volume":"215","author":"Chien","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humpath.2018.01.005_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2018.01.005_bb0095","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0100","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T cell lymphoma","volume":"4","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2018.01.005_bb0110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0115","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/ajg.2011.283","article-title":"Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease","volume":"106","author":"Herrinton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study","volume":"108","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2018.01.005_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.1994.tb06611.x","article-title":"Increase of circulating gamma\/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease","volume":"98","author":"Giacomelli","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0135","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.156.6.2331","article-title":"Increased frequency of abnormal gamma delta T cells in blood of patients with inflammatory bowel diseases","volume":"156","author":"Soderstrom","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0140","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/gut.2009.181982","article-title":"Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle","volume":"58","author":"Sokol","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2018.01.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017890","article-title":"Infliximab induces clonal expansion of gammadelta-T cells in Crohn's disease: a predictor of lymphoma risk?","volume":"6","author":"Kelsen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.01.005_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0155","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.humpath.2011.01.034","article-title":"Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases","volume":"42","author":"Lu","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0160","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and gammadelta T-cell large granular lymphocytic leukemia: A clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00428-016-2006-x","article-title":"Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma","volume":"469","author":"Karpate","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2018.01.005_bb0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2011.01741.x","article-title":"Relapsed hepatosplenic T-cell lymphoma heralded by a solitary skin nodule","volume":"38","author":"Hocker","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.humpath.2015.11.010","article-title":"Dyspoiesis of patients with hepatosplenic T-cell lymphoma is unlikely a manifestation of an associated myelodysplastic syndrome","volume":"50","author":"Yabe","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood-2015-10-676544","article-title":"Hepatosplenic T-cell lymphoma: an acute leukemia presentation","volume":"127","author":"Arnoux","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0190","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.clml.2015.11.019","article-title":"Hepatosplenic T-cell lymphoma mimicking acute myeloid leukemia","volume":"16","author":"Pizzi","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.humpath.2018.01.005_bb0195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic T gamma\/delta lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2018.01.005_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102977","article-title":"Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma","volume":"9","author":"Finalet Ferreiro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.01.005_bb0215","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.01.005_bb0220","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2018.01.005_bb0225","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairismagi","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.13952","article-title":"Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia","volume":"173","author":"Lopez","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0235","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2018.01.005_bb0240","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0245","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2018.01.005_bb0250","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2018.01.005_bb0255","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2018.01.005_bb0260","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.01.005_bb0265","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ng.2894","article-title":"Identification of functional cooperative mutations of SETD2 in human acute leukemia","volume":"46","author":"Zhu","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2018.01.005_bb0270","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.humpath.2018.01.005_bb0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2141.2010.08494.x","article-title":"Large granular lymphocytic leukaemia pathogenesis and management","volume":"152","author":"Dearden","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.20853","article-title":"Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature","volume":"82","author":"Alekshun","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2141.2001.02559.x","article-title":"T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chains","volume":"112","author":"Boehrer","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0290","first-page":"1514","article-title":"Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest","volume":"10","author":"Tordjman","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0295","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V84.7.2315.2315","article-title":"CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia","volume":"84","author":"Gentile","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0300","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V87.4.1474.bloodjournal8741474","article-title":"Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes","volume":"87","author":"Macon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.01.005_bb0305","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ijc.11647","article-title":"Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia","volume":"108","author":"Daibata","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2018.01.005_bb0310","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clml.2013.12.017","article-title":"Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?","volume":"14","author":"Ok","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.humpath.2018.01.005_bb0315","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1309\/AJCPJSA1E1YWSZEY","article-title":"Clinicopathologic, immunophenotypic, cytogenetic and molecular features of \u03b3\u03b4 T-cell large granular lymphocytic leukemia: an analysis of 14 patients suggests biologic differences with \u03b1\u03b2 T-cell large granular lymphocytic leukemia","volume":"144","author":"Yabe","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1309\/AJCPTFFQ18JMYKDF","article-title":"Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-\/CD8-gammadelta T-cell large granular lymphocytic leukemia","volume":"136","author":"Chen","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2404112","article-title":"TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells","volume":"20","author":"Sandberg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0330","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1002\/ajh.24711","article-title":"Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States","volume":"92","author":"Durani","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0335","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.01.005_bb0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.humpath.2018.01.005_bb0345","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2018.01.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.43","article-title":"Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma","volume":"5","author":"Rashidi","year":"2015","journal-title":"Blood Cancer J"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T11:40:10Z","timestamp":1693395610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":70,"alternative-id":["S0046817718300066"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.01.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}